UNSPSC 51451501: Dichlorophen

This classification denotes an antihelminthic agent with the molecular formula C13H10Cl2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T1J0JOU64O, chemically known as 5,5-dichloro-2,2-dihydroxydiphenylmethane but generally known as dichlorophen, which bears US NIH Compound Identifier 3037. European Medicines Agency schedules Dichlorophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07085MIG.

UNSPSC 51451501 Dichlorophen, a Commodity code, does not reflect the pharmaceutical and medical supply products actually being solicited under it in recent state and local opportunities. The recent opportunities tagged to this code involve naloxone and drug deactivation systems, first aid and rescue supplies, generic pharmaceuticals and over-the-counter products, and direct-to-manufacturer prescription fulfillment arrangements — none of which are dichlorophen or closely related to it. The code shows a significant mismatch between its nominal scope and current procurement activity, suggesting either a cataloging error in the tagging system or that this code is being used as a catch-all for medical and pharmaceutical procurement that does not map cleanly to the UNSPSC hierarchy.

Recent solicitation activity spans state health agencies, county health departments, city fire departments, and multistate cooperative purchasing alliances. Seminole County, Florida, issued an invitation to bid (IFB 60459723LAS) in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries due July 26, 2023. The City of Tampa's Purchasing Department issued an invitation to bid (26P00145) in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a response deadline of March 13, 2026, designated as a sheltered market opportunity for certified small local business enterprises. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802) in January 2026 for generic multi-source pharmaceuticals and over-the-counter products across participating state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026. The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013) in April 2026 to gather vendor capabilities regarding direct-to-manufacturer prescription programs. The geographic activity centers on Florida, Texas, Minnesota, and Oregon, with procurement spanning county, city, state, and regional cooperative entities.